Cargando…
Molecularly Targeted Therapy for Neuroblastoma
Neuroblastoma is the most common extra-cranial solid tumor encountered in childhood and accounts for 15% of pediatric cancer-related deaths. Although there has been significant improvement in the outcomes for patients with high-risk disease, the therapy needed to achieve a cure is quite toxic and fo...
Autor principal: | Greengard, Emily G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210520/ https://www.ncbi.nlm.nih.gov/pubmed/30326621 http://dx.doi.org/10.3390/children5100142 |
Ejemplares similares
-
Molecular targeting therapies for neuroblastoma: Progress and challenges
por: Zafar, Atif, et al.
Publicado: (2020) -
Applications and prospects of targeted therapy for neuroblastoma
por: Wang, Jing, et al.
Publicado: (2020) -
The emerging molecular pathogenesis of neuroblastoma: implications for improved risk assessment and targeted therapy
por: Van Roy, Nadine, et al.
Publicado: (2009) -
Henoch-Schönlein Purpura Presenting in Association With Neuroblastoma: A Case Report
por: Alfath, Zineb, et al.
Publicado: (2020) -
Targeting autophagy in neuroblastoma
por: Huang, Siqi, et al.
Publicado: (2020)